Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stimulants and the developing brain.

Susan L Andersen1

  • 1Laboratory of Developmental Neuropharmacology, McLean Hospital and Harvard Medical School, 115 Mill Street, Belmont, MA 02478, USA. sandersen@mclean.harvard.edu

Trends in Pharmacological Sciences
|April 30, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increasing CB2 Receptor Activity after Early Life Stress Prevents Depressive Behavior in Female Rats.

Biomolecules·2024
Same author

Correction: Commentary: Improving the Effectiveness and Utility of the Helping to End Addiction Long-Term (HEAL) Prevention Cooperative: A Full Translational Framework.

Prevention science : the official journal of the Society for Prevention Research·2023
Same author

Commentary: Improving the Effectiveness and Utility of the Helping to End Addiction Long-Term (HEAL) Prevention Cooperative: A Full Translational Framework.

Prevention science : the official journal of the Society for Prevention Research·2022
Same author

Neuroinflammation, Early-Life Adversity, and Brain Development.

Harvard review of psychiatry·2022
Same author

Novelty preferences and cocaine-associated cues influence regions associated with the salience network in juvenile female rats.

Pharmacology, biochemistry, and behavior·2021
Same author

This is your teen brain on drugs: In search of biological factors unique to dependence toxicity in adolescence.

Neurotoxicology and teratology·2020
Same journal

Targeting developmental reprogramming: hPSC insights for cancer interception.

Trends in pharmacological sciences·2026
Same journal

July 2026 issue first authors.

Trends in pharmacological sciences·2026
Same journal

Chronobiomaterials for circadian-aligned brain therapeutics.

Trends in pharmacological sciences·2026
Same journal

Biosensors for translatable GPCR bias.

Trends in pharmacological sciences·2026
Same journal

ECM stiffness and epigenetics in organ fibrosis.

Trends in pharmacological sciences·2026
Same journal

Which HTT transcript to lower?

Trends in pharmacological sciences·2026
See all related articles

Stimulant medications for attention deficit hyperactivity disorder (ADHD) may alter brain development trajectories in children. Long-term effects depend on exposure timing, age, and sex, impacting brain structure and function into adulthood.

Area of Science:

  • Neuroscience
  • Developmental Psychology
  • Pharmacology

Background:

  • Stimulant medications have been used for attention deficit hyperactivity disorder (ADHD) for nearly 70 years.
  • The long-term effects of these medications on childhood and adolescent brain development remain incompletely understood.
  • Brain maturation involves synaptic overproduction and elimination, influenced by genetics and experience.

Purpose of the Study:

  • To investigate the influence of stimulant drug exposure on brain development during critical childhood and adolescent periods.
  • To understand how the timing and duration of stimulant exposure impact neurodevelopmental trajectories.
  • To explore sex-specific effects and long-term consequences of early stimulant treatment.

Main Methods:

  • Utilized preclinical studies to examine the effects of stimulant exposure on brain development.

Related Experiment Videos

  • Analyzed the impact of chronic, pre-pubertal stimulant exposure on brain structure and function.
  • Investigated how timing of exposure (childhood vs. adolescence) and age at examination influence outcomes.

    • Main Results:

    • Chronic, pre-pubertal stimulant exposure alters the developmental trajectory of brain structure and function.
    • Exposure timing, age at examination, and sex significantly influence observable neurodevelopmental effects.
    • Stimulant effects manifest differently depending on the developmental stage at which exposure occurs.

    Conclusions:

    • Stimulant medications can modify the developmental course of the brain, leading to altered adult brain topography.
    • Understanding these developmental impacts is crucial for optimizing ADHD treatment and managing other childhood disorders.
    • Preclinical data offers insights into potential new therapeutic strategies for neurodevelopmental conditions.